We are live on ! Find out more
STAA icon

STAAR Surgical

185 hedge funds and large institutions have $1.34B invested in STAAR Surgical in 2019 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 63 increasing their positions, 72 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more call options, than puts

Call options by funds: $9.64M | Put options by funds: $3.86M

22% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 23

5% more capital invested

Capital invested by funds: $1.28B → $1.34B (+$66.8M)

2% more funds holding

Funds holding: 181185 (+4)

0% more funds holding in top 10

Funds holding in top 10: 55 (0)

1.78% less ownership

Funds ownership: 90.64%88.86% (-1.8%)

13% less repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 72

Holders
185
Holders Change
+4
Holders Change %
+2.21%
% of All Funds
4%
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.11%
New
28
Increased
63
Reduced
72
Closed
23
Calls
$9.64M
Puts
$3.86M
Net Calls
+$5.79M
Net Calls Change
-$1.75M
Name Holding Trade Value Shares
Change
Change in
Stake
RHJA
76
Rice Hall James & Associates
California
$1.59M -$73.4K -2,075 -4%
HIM
77
Hillsdale Investment Management
Ontario, Canada
$1.51M
Ameriprise
78
Ameriprise
Minnesota
$1.49M +$676K +19,113 +79%
SG Americas Securities
79
SG Americas Securities
New York
$1.46M -$1.25M -35,320 -45%
Axa
80
Axa
France
$1.4M -$1.58M -44,600 -52%
Comerica Bank
81
Comerica Bank
Texas
$1.38M +$92K +2,600 +8%
BA
82
Bristol Advisors
Pennsylvania
$1.37M +$637K +18,000 +82%
CS
83
Candriam SCA
Luxembourg
$1.33M
Barclays
84
Barclays
United Kingdom
$1.3M +$482K +13,623 +56%
Los Angeles Capital Management
85
Los Angeles Capital Management
California
$1.15M
N
86
Nuveen
North Carolina
$1.13M +$132K +3,732 +13%
Robeco Institutional Asset Management
87
Robeco Institutional Asset Management
Netherlands
$1.11M +$906K +25,614 +372%
Jacobs Levy Equity Management
88
Jacobs Levy Equity Management
New Jersey
$1.11M +$354K +10,000 +44%
AWE
89
Avidian Wealth Enterprises
Texas
$1.1M +$1.14M +32,200 New
Tudor Investment Corp
90
Tudor Investment Corp
Connecticut
$1.06M +$1.09M +30,907 New
ARTA
91
A.R.T. Advisors
New York
$1.01M -$2.68M -75,847 -72%
Citigroup
92
Citigroup
New York
$996K -$123K -3,475 -11%
Manulife (Manufacturers Life Insurance)
93
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$985K +$74.4K +2,104 +8%
State Board of Administration of Florida Retirement System
94
State Board of Administration of Florida Retirement System
Florida
$984K -$6.37K -180 -0.6%
AIG
95
American International Group
New York
$958K -$32.1K -908 -3%
TAM
96
Tocqueville Asset Management
New York
$915K +$74.3K +2,100 +9%
WJA
97
Williams Jones & Associates
New York
$874K -$1.77K -50 -0.2%
PAM
98
Panagora Asset Management
Massachusetts
$855K
FG
99
Formula Growth
Quebec, Canada
$855K +$885K +25,000 New
SO
100
STRS Ohio
Ohio
$847K

STAA Hedge Fund Activity: Q1 2019 in Review

185 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in STAAR Surgical (STAA) for Q1 2019, worth a combined $1.34B — up 5.2% from $1.28B a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new STAA positions and 23 closed out — a net gain of 5 holders — while 63 added to existing stakes and 72 trimmed.

The largest buyer was Waddell & Reed Financial, opening a new position worth an estimated $27.4M. The largest seller was Renaissance Technologies, cutting an estimated $18.7M.

  • 185 institutional investors held STAAR Surgical (STAA) as of Q1 2019, up from 181 in Q4 2018.
  • Funds reported $1.34B of STAAR Surgical stock for Q1 2019, up 5.2% quarter-over-quarter.
  • 28 funds opened new STAAR Surgical positions in Q1 2019 and 23 closed out, a net change of +5 holders.
  • The largest STAAR Surgical buyer in Q1 2019 was Waddell & Reed Financial, an estimated $27.4M added.
  • The largest STAAR Surgical seller in Q1 2019 was Renaissance Technologies, an estimated $18.7M sold.

Based on aggregated 13F filings for Q1 2019.